Sept. 17, 2018 Price forecast | 2 weeks: 0.54% | 1 month: 0.69% | 3 months: 0.68%


XENT stock forecast

Our latest prediction for Intersect ENT, Inc.'s stock price was made on the Sept. 17, 2018 when the stock price was at 29.00$.

In the short term (2weeks), XENT's stock price should outperform the market by 0.54%. During that period the price should oscillate between -6.17% and +7.43%.

In the medium term (3months), XENT's stock price should outperform the market by 0.68%. During that period the price should oscillate between -16.00% and +21.72%.


About Intersect ENT, Inc.

Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA.

At the moment the company generates 108M USD in revenues.

On its last earning announcement, the company reported a loss of -0.76$ per share.

The book value per share is 4.01$

Intersect ENT, Inc. website


Three months stock forecastSept. 17, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
108M 79.20% -25M -23.10% -23M -0.76 - - 30M 4.01 -14M -2M -16M